Home›Companies›Biotech & Pharma›Vizgen

Vizgen, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 12, 2026·Suggest an edit

About Vizgen

Vizgen is a private company based in Waltham, Massachusetts. It has reported $187,488,706 raised in five offerings on Form D since October 2019. Its chief executive is Robert Carson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 29, 2025Jan 12, 2026$47,788,714of $50.0M target9$5.3MEquity, OptionsRule 506(b)Form D ↗
Oct 1, 2025Oct 7, 2025$3,500,000of $9.5M target7$500KDebtRule 506(b)Form D ↗
Apr 21, 2022May 5, 2022$85,199,997of $105.1M target15$5.6MEquityRule 506(b)Form D ↗
Mar 26, 2021Apr 8, 2021$36,999,998fully sold12$3.0MEquityRule 506(b)Form D ↗
Oct 1, 2019Oct 15, 2019$13,999,997fully sold3$4.6MEquityRule 506(b)Form D ↗
Total, five offerings$187,488,706

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vizgen's Form D filed Jan 12, 2026.

AJ
Andrea Jackson
Director
Also a director at Ultivue.
SL
Simona Levi
Executive officer
RC
Robert Carson
President and CEO, director
Also a president and director at Ultivue.
KC
Keith Crandell
Director
Also a director at Ultivue.
MP
DW
David Walt
Director
Also a director at Ultivue.

Earlier filings also listed Terry Lo (director, last listed Oct 2025), Christian Urhich (director, last listed Oct 2025), Chris Guiffre (executive officer, last listed Oct 2025), Seth Benson (executive officer, last listed Oct 2024), Philip Gardella (executive officer, last listed May 2022), Marijn Dekkers (director, last listed May 2022), Dr. Philip Gardella (executive officer, last listed Oct 2019) and Dr. Peidong Wang (executive officer and director, last listed Oct 2019).

Sources

  1. SECVizgen, Inc. filing history